Tetra Therapeutics
Tetra is a pharmaceutical drug development company developing medicines for Alzheimer's Disease, Traumatic Brain Injury, and Schizophrenia.
12/07/2022
Tetra Therapeutics Initiates Phase 2b/3 Clinical Studies of Investigational Drug BPN14770 in Fragile X Syndrome Tetra Therapeutics, a Shionogi Group Company, focused on the development of compounds for the treatment of brain disorders associated with cognitive a
Our Story
Tetra Therapeutics is a clinical phase drug development company developing medicines for Alzheimer's Disease, Fragile X Syndrome, Traumatic Brain Injury, and Schizophrenia.